Detailed polychlorinated biphenyl (PCB) signatures and chiral Enantiomer Fractions (EFs) of CB-95, CB-136 and CB-149 were measured for 30 workers at a transformer dismantling plant. This was undertaken to identify sources of exposure and investigate changes to the PCB signature and EFs over different exposure periods. Approximately 1.5 g of serum was extracted and PCB signatures were created through analysis by comprehensive twodimensional gas chromatography with time-of-flight mass spectrometry (GCxGC-TOFMS) and EFs calculated by analysis by gas chromatography with high resolution mass spectrometry (GC-HRMS). A total of 84 PCBs were identified in the serum samples with concentrations of the 7 indicator PCB ranging from 11 -350 ng g -1 of serum (1.2 -39 µg g 
Introduction
1 Polychlorinated biphenyls (PCBs) are a group of 209 chlorinated organic compounds that 2 were widely used throughout the 20 th century. While PCBs have been largely phased out of 3 commercial/industrial use, they remain an important legacy contaminant (O'Sullivan and 4 Sandau, 2013 ). They are highly persistent and can still be found in closed systems in some 5 countries, e.g. as dielectric fluids in electrical equipment and transformers. Many of these 6 transformers containing PCBs are in the process of being replaced, and this process therefore 7 presents the potential of PCB exposure for humans working in dismantling plants. In these 8
instances it is important not only to determine the extent of the exposure, along with the 9 potential risks to human health, but also to establish the source of the contamination and age 10 date the exposure. 11
As PCBs were produced as commercial mixtures, such as Aroclors, each blend has a specific 12 congener profile (signature) based on the relative proportions of each PCB in the total 13 mixture. This signature can be used to easily distinguish commercial mixtures, however 14 environmental investigations involving humans are more complex as there are often multiple 15 potential sources of PCB exposure. The signature can be altered by changes such as 16 volatilization, dissolution and biodegradation (Jaspers et al., 2013; Johnson et al., 2006) . The 17 signature in humans can also vary depending on different exposure pathways e.g. oral, 18 inhalation or dermal, and can be altered through post uptake processes such as 19 biotransformation and elimination (Jaspers et al., 2013; Megson et al., 2013a) . If a dominant 20 source of exposure can be identified then alterations to this signature from post uptake 21 processes such as biotransformation and elimination may provide useful information to 22 distinguish between recent and prolonged exposure. The sera of an individual who has been 23 historically exposed may contain higher proportions of the PCBs that are more resistant to 24 biotransformation and elimination. Due to all of the subtle changes that can occur to the PCB 25 profile, when attempting to identify the source of exposure it is imperative that signatures are 26 created using detailed congener specific datasets. Analysis using comprehensive two 27 dimensional chromatography has proven to be an excellent technique for this purpose as it is 28 able to separate over 190 individual PCB congeners (Focant et Of the 209 PCBs there are 19 which are predicted to exist as stable atropisomers (Oki, 1983) . 31
They have a high degree of ortho chlorine substitution which inhibits rotation, and an 32 unsymmetrical meta and para substitution on each biphenyl, resulting in two optical isomers. 33
In commercial mixtures both enantiomers are produced in equal proportions; however in 34 animals, metabolic processes such as enzyme mediated oxidation have been proven to 35 preferentially target one stereoisomer, resulting in atropisomeric enrichment (Harrad et al. 36 2006; Wong et al., 2002; Wu et al., 2014) . Therefore, the sera of an individual who has 37 recently been exposed to a commercial PCB mixture may be expected to contain near equal 38
proportions of each stereoisomer whereas the sera of a historically exposed individual may 39
show a greater degree of fractionation. However, this signal is likely to be complicated by 40 interferences such as other background sources of PCBs. 41
The goal of this study was to determine if PCB signatures and enantiomer fractions could be 42 used to identify the source of contamination and distinguish between recent and prolonged 43 exposure periods for 30 workers at a transformer dismantling plant. 44
Experimental 45

Sample collection
46
Samples of whole blood were collected from 30 people working at a transformer dismantling 47 plant in Europe. Samples were obtained from workers performing a range of different roles at 48 the plant, including workers on the dismantling floor who were likely to have had direct 49 contact with PCBs and those who were not expected to have had any direct contact with 50
PCBs such as administrative staff and a security guard. Samples were obtained from 51 employees who had been working at the plant from 3 -21 years. However, information on 52 occupation and length of time at the plant was not available for three participants (id no. S028, 53 S029 and S030). A 10 mL sample of whole blood was obtained from each worker, the blood 54 was collected in vacutainers, then centrifuged and the serum collected and stored at -20 ˚C. 55
Total lipid concentrations were determined by enzymatic analysis which was performed by a 56 sub-contractor clinical laboratory on a dedicated 2 mL serum sub-sample. Four types of lipids 57 were targeted and measured; triglycerides, total cholesterol, non-esterified (free) cholesterol, 58 and phospholipids. Sample sizes were as follows: triglycerides (2 µL), total cholesterol (2 59 µL), non-esterified (free) cholesterol (50 µL), and phospholipids (20 µL). Total lipid 60 concentrations were estimated using the summation method of Akins et al. (1989) . The total 61 lipid content was expressed in g L -1 . For the inter-conversion of volumetric and gravimetric 62 data, a value of 1.026 g mL -1 for serum specific gravity was used. 63
Sample preparation
64
All reagents required for extraction and clean-up were sourced specifically for dioxin, furan 65 and PCB analysis or of the closest grade available of similar quality. Approximately 1.5 g of 66 serum was accurately weighed (to 4 decimal places) and transferred to a vial and 5 µL of 67 13 C 12 labelled CB-60, CB-127 and CB-159 at a concentration of 100 pg µL -1 (CIL-EC-5370 68 EN-1948-4 PCB sampling standard) was added to determine recovery. A volume of formic 69 acid equal to the mass of the sample was added to the serum followed by the same volume of 70 high purity water. During each addition the solution was vortexed and allowed to degas for 71 several minutes. The whole extract was then applied to a C 18 SPE cartridge (1 g / 6 mL) and 72 the PCBs were eluted with hexane. The eluent was treated using EPA method 3665A 73 sulphuric acid / permanganate clean-up followed by EPA method 3620 Florisil clean-up. 74
Extracts were reduced to approximately 50 µL by nitrogen evaporation and 100 µL of 13 Procedural blanks were prepared for each batch of 8 samples. Contamination with CB-11 was 88 identified in the blanks and so this congener was excluded from the results. All samples were 89 spiked with two sets of 13 C 12 labelled internal standards which were used to quantify PCB 90 concentrations and calculate recovery. Quantification was undertaken through isotope 91 dilution; calibration data was produced for 41 of the most commonly encountered congeners 92 (CIL-EC-4133 DSJ PCB Mixture). Quantification of other congeners present in the samples 93 was undertaken using the calibration data from the closest eluting calibrated congener with 94 the same level of chlorination. Recovery for all samples was within the accepted range 95 specified by EPA method 1668C (10 % to 145 %), the mean recovery was 55 % (± 16 %; 1σ). 96
Concentrations were recovery corrected and lipid normalised and reported as ng g -1 lipid 97 weight. The instrument limit of detection (LOD) was estimated empirically using the 98 calibration standard mixtures, LODs for CB-18 and CB-206 were calculated at a 99 concentration of at 1 and 50 pg μL -1 respectively. Accuracy and precision were measured for 100 the sum of the European Union 7 indicator congeners (EC7; CB-28, CB-52, CB-101, CB-118, 101 CB-138, CB-153, CB-180) by analysing a 10 ng µL -1 Aroclor 1248 standard three times. The 102 accuracy of the sum of the EC7 congeners for the three samples was 105% (± 0.9%; 1 σ). 103 humans are in the range of 0.1 -10 ng g -1 serum (0.01 -1 µg g -1 lipid) (Longnecker, 2001) . 132
Chiral analysis by GC-HRMS
This shows that some workers had close to background exposure whereas others had elevated 133 PCB concentrations indicating that they may have been exposed to PCBs through their 134 occupation. The PCB concentrations in the different workers are summarised in Table 1 The PCB signatures of the workers were assessed using principal component analysis (PCA). 179
Where a PCB was not detected it was included in the dataset as a "0". As part of the data 180 quality check, other values such as LOD/2 were substituted for "0", but these had no 181 observable effect on the data output and so the "0"s were retained. To reduce any bias from a 182 high proportion of non-detects for a specific congener, PCBs that were not detected in over exposure from capacitors in electrical equipment (Luotamo et al., 1993) .
Concentrations of 259
PCBs in individuals from this group were similar to those from the group with prolonged 260 exposure to A1260. Therefore, the results indicate that this group was exposed to an 261 additional source of PCBs through the inhalation of PCBs, possibly through leaching of 262 materials at the home rather than from their workplace (Figure 2) . 263
Enantiomeric fractions 264
To further elucidate the potential sources of exposure to these individuals we also examined 265 the enantiomer signatures of thee chiral PCBs (CB-95, CB-136 and CB-149) in the samples 266 to ascertain if there were any trends in enantio-specific processing of these congeners that 267 could be related to variations in the exposure of the workers, as well as potentially providing 268 further insight into the pharmacokinetics of these pollutants in humans. 
Conclusions
312
Identifying the source of contamination and age dating human exposure to PCBs is a highly 313 complex task. This is due to the wide range of PCB sources that humans are exposed to along 314 with different exposure pathways and processes such as volatilization, dissolution, 315 biodegradation and post uptake processes that can all alter the original PCB signature. 316
However, by considering PCB concentrations along with detailed congener specific 317 signatures it was possible to identify different sources of contamination and gain an insight 318 into both the magnitude and duration of exposure. 
